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Objectives: To confirm linkage of the locus of the ma­
jor form of hyperekplexia to markers on chromosome 
5q, to screen for a point mutation in the gene encoding 
the a l subunit of the glycine receptor, and to investi­
gate whether the putative “minor” form of hyperek­
plexia, consisting of an excessive startle response with­
out stiffness, is based on the same genetic defect as the 
major form.
Design: A survey of various symptoms of hyperek­
plexia was performed in the Dutch pedigree. Linkage stud­
ies were performed for these symptoms.
Setting: Subjects were visited at home, and the genetic 
study was performed at University Hospital Leiden, (the 
N etherlands).
Patients: A history was taken from 76 subjects in the 
pedigree, and neurologic examinations were performed 
on 61 subjects from four generations of the pedigree.
M ain Outcome Measures: The main outcome mea-
*
sures were lod scores for markers on chromosome 5q for 
the major and minor forms of hyperekplexia and periodic
leg movements during sleep. Mutations in the a l subunit 
of the glycine receptor were detected by screening the ex­
ons with denaturing gradient gel electrophoresis.
Results: Exaggerated startle responses were reported in 
44 patients. The major form consisted of stiffness in ad­
dition to the excessive startle reaction and occurred in 
28 subjects. Sixteen of 44 subjects had startle responses 
without stiffness, indicating the minor form. Linkage was 
found between markers CSF1-R, D5S209, and D5S119
and the disease locus for the major form, but not for the 
minor form. The a l subunit of the glycine receptor 
showed a G to A transition mutation in codon 271 for 
the major form, but not for the minor form.
Conclusions: Linkage and an abnormal glycine recep­
tor were found only in the major form of hyperekplexia. 
Recognition of a major form is based on additional stiff­
ness. This is therefore the most important diagnostic 
symptom. The minor form is not a different expression 
of the same genetic defect and may represent a normal 
but pronounced startle response.
(Arch Neurol. 1995;52:578-582)
y p e r e k p l e x i a , or startle years of life. The severity of the disorder
disease, is an autosomal in adults is determined by the frequency
dominant disorder char- of startle responses; it varies consider-
acterizedby exaggerated ably, not only between subjects but also
startle reactions to unex­
pected, particularly auditory, stimuli.
over time.
From the Department of
Besides patients with the major form, 
Suhren et al1 described the syndrome in patients with a putative “minor” form were 
detail in a large Dutch family in 1966. Sub- described based on excessive startle reac- 
sequent reports2'8 have confirmed its fa- tions without stiffness. In the Dutch fam- 
milial occurrence. In the Dutch family, two ily, patients with the major form had
Neurology, University Hospital forms of expression of this disease were appeared to pass on the minor form of 
Leiden (the Netherlands) recognized. The major form is character- the disease to their children; in one case,
(Drs Tijssen, Boerman, and 
Padberg); the Department of
Human Genetics, University of 
Leiden (Dr van Deutekom, 
Sandkuijl, and Frants); and 
the Department of Biological 
Chemistry, University of 
California, Irvine (Drs Shiang 
and Wasmuth).
ized by excessive startle reactions fol- a patient with what seemed the minor 
lowed by a short period of generalized stiff- form had offspring with the major form, 
ness, during which voluntary movements 
are impossible. Patients remain con­
scious during the response. The patients 
with the major form showed an extreme 
generalized stiffness immediately after 
birth, which normalizes during the first
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PATIENTS AND METHODS LINKAGE ANALYSIS
PATIENTS
Statistical analysis was performed by the computer pro­
gram Linkage package, version 5.04.2i Hyperekplexia was 
assumed to be an autosomal dominant disease with com- 
We reinvestigated die Dutch family with hyperekplexia plete penetrance. Frequencies of marker alleles were deter- 
described by Suhren et al1 in 1966 and included a new mined in spouses and in the family with hyperekplexia. Link-
generation (Figure 1). A history was obtained from 76 age analysis was performed on individual, sibships and on
individuals (32 patients and 44 unaffected relatives), and the complete pedigree; evidence for or against linkage is given
a neurologic examination was performed in 61 individu- as logarithm base 10 of the odds in favor of linkage (lod score),
als (31 patients and 30 unaffected relatives) from four Initially, only the classic form of hyperekplexia was scored
generations. In 15 subjects, no neurologic examination in ; linkage am minor form or PLMS
was performed: one patient (patient IV-3) refused, while were treated as unaffected. The hypothesis of the excessive 
14 unaffected family members lived far from our hospi- startle reaction being a minor form of hyperekplexia was in- 
tal. Blood samples were obtained from 59 of the 61 indi­
viduals examined (two patients were young children) 
and 15 spouses.
1 | ( * ( ï  Vxx 1 A* It pane î minor tor
had inherited the marker alleles that were linked to the clis
ease gene in ilv. The an i zone
The major form of hyperekplexia was defined by a his- on chromosome S being responsible for PLMS in this fam- 
tory of exaggerated startle responses to auditive, tactile, or ily was investigated separately; for this purpose, the occur- 
visual stimuli and the presence of stiffness following the renee of excessive startle responses or stiffness was ne-
startle reaction. In the absence of stiffness, the minor form 
was diagnosed. In addition, the presence or absence of PLMS 
was verified, as either noted by the patients themselves or
their partners. Patients were also included in this category SCANNING EXONS FOR POINT MUTATIONS
glected. The frequency of PLMS in the general population 
was assumed to be approximately 5%,~4
when they experienced sudden body jerks on falling asleep 
at least once a week.
BY DGGE AND SEQUENCING OF GLRA1
GENETIC MARKER ANALYSIS
Polymerase chain reaction primers within intron se­
quences of the GLRA1 were designed to amplify all exons 
from genomic DN A of affected individuals and controls (R.S., 
Genomic DNA was isolated from freshly collected blood, oral communication, 1994, data not shown). The goal was 
as previously described.17 Analysis of microsatellite to amplify the exons from DNA from individuals with hy-
markers was performed with multiplex polymerase 
chain reactions on all individual DNA samples.l7,ls The 
microsatellite markers interleukin-9,19 D5S2I0, 
D5S207,20 CSF1-R,21 D5S209,1H D5S119,20 D5S422,22 and 
D5S21120 were included (Figure 2). Reaction products 
were separated on a 6% denaturating polyacrylamide gel 
containing 7-mol/L ureum, The gels were fixed, dried, 
and subjected to autoradiography for 12 to 18 hours, 
without an intensifying screen. Marker genotypes were 
subsequently determined for each individual by visual 
inspection.
perekplexia and to use DGGE to scan for DNA sequence 
alterations unique to the affected individuals,16 Exons show­
ing an aberrant DGGE pattern were cloned and se­
quenced.
Polymerase chain reaction products from exon 6 were 
directly cloned into the pCRII vector with use of a cloning 
kit (Invitrogen TA, San Diego, Calif).10 Six i
were sequenced on an automated sequencing apparatus 
(Pharmacia ALF, Uppsala, Sweden). Mutations were de­
tected by comparing cloned sequences with the published 
cDNA sequence.“'
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Figure 1. Hyperekplexia pedigree. The numbers in the pedigree are similar to the numbers of the original pedigree.’ In the fifth and sixth generations, new 
subjects are included.
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Accordingly, the two forms were considered to repre­
sent variations in expression of the same disease gene. 
In other families segregating for hyperekplexia, the oc­
casional occurrence of the minor form has been con­
firmed.2,8'10
Autosomal dominant inheritance with nearly com­
plete penetrance and variable expressivity is seen in most 
pedigrees.2'5Al1,12 On the basis of findings obtained in small 
sibships, some authors suggested an autosomal reces­
sive inheritance pattern or the occurrence of new muta- 
tions.2’4,6’8'13
Hypnagogic myoclonus and periodic leg move­
ments during sleep (PLMS) are frequently associated with 
hyperekplexia. 2'i1'H' l0,1U i'1'5 The occurrence of PLMS in un­
affected sibs has not been signaled.
Recently, Ryan et al7,12 mapped a hyperekplexia lo­
cus on chromosome 5q33-q35 in four families with the 
major form of hyperekplexia. Further studies identified 
point mutations in the gene encoding the a l subunit of 
the glycine receptor (GLRA1). Two different mutations 
were found in the same position, resulting in substitu­
tion of an uncharged amino acid (leucine or glutamine) 
for Arg271 in the mature protein.16 Neither the minor 
form of hyperekplexia nor the occurrence of PLMS was 
discussed in those studies.
The first aim of our study was to confirm linkage of 
the major form of hyperekplexia on chromosome 5q33 in 
the Dutch hyperekplexia pedigree. Second, we tested 
whether the family members with the putative minor form 
had inherited the chromosome with the major hyperek­
plexia gene defect, as determined by haplotyping. The third 
aim was to record the occurrence of PLMS in the pedi­
gree in relation to the genetic markers. Finally, we scanned 
the gene for GLRA1 for point mutations using denatur­
ing gradient gel electrophoresis (DGGE) in patients with 
the major and minor form, and sequenced exon 6.
R E S U L T S
stimuli were found in 44 patients (22 male and 22 fe­
male), 32 of whom were alive at the time of investigation. 
Stiffness in addition to the startle reaction occurred in 28 
of the 44 patients, indicating, according to the definition, 
the major form; 23 of these were known to have had gen­
eralized stiffness directly after birth. No reliable informa-
tion could be obtained concerning the neonatal occur­
rence of stiffness in the remaining five individuals of 
generation III (Figure 1). All patients who were known to 
have had stiffness at birth also suffered from stiffness in re­
lation to the startle reaction. Among 44 patients with ex­
cessive startle reactions, 16 had never manifested stiffness 
either after startle or at birth; these patients had the minor 
form of hyperekplexia.
The transmission of the major form of hyperekplexia 
in this family was consistent with autosomal dominant in­
heritance. The major form was frequently passed on as the 
major form and four times as the minor form. However, 
those with the minor form only passed on the minor form, 
never the major form. Patient III-8 seemed to be one ex­
ception to this rule (Figure 1). In 1966, he had reported 
an excessive startle reaction without stiffness and passed 
the major form of the disease on to his children. However, 
based on detailed family history of several close relatives, 
who reported to have seen him fall several times owing to 
generalized stiffness in relation to his startle reaction, he 
is now considered to have the major form.
In Table I , evidence for linkage between each of 
the chromosome 5 markers and the major form of hy­
perekplexia is presented as lod scores. Close linkage with­
out recombination was found between markers CSF1-R, 
D5S209, and D5S119 and the disease locus. For these 
markers, an identical haplotype was found in all 19 pa­
tients with the major form, indicating tight linkage.
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Figure 2. Sex-averaged map of chromosome 5q21-qter!!lsti and used 
markers.
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Table 1. The Lod Scores for Markers on Chromosome 5q for the Major Form of Hyperekplexia
r
Thêta*
tmtm Marker
Marker 0.0 0.01 0.05 0.1 0.2 0.3 0.4 Heterozyg
D5SIL9 **~QÜ 1.708 3.933 4.395 4.007 2.955 1.527 0.62
D5S210 mm QQ -6.054 -0.341 1.613 2.688 2.437 1.461 0,75
D5S207 — 00 -3.074 -0.511 0.377 0.868 0.754 0.385 0.69
CSF1-R 6.005 5.890 5.417 4.800 3.480 2.057 0.618 0,86
D5S209 9.894 9.754 9.170 8.391 6.664 4.682 2.409 0.71
D5S119 — 00 8.897 9.035 8.535 6,980 4.975 2.569 0.49
D5S422 "“ "ÖÖ —9.268 -4.796 -3.168 -1.734 “ 0.965 —0.438 0.84
D5S211 — 00 14.973 ~6.864 -3.665 -1.035 -0.061 0.182 0.72
«DOT m *
* Theta is the recombination fraction; heterozygosity indicates the allele frequency of the different markers in the population.
«ft*
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Of the 10 patients with the putative minor form, three 
(patients 111-5, IV-11, and V-66) had a haplotype simi­
lar to those patients with the major form, but seven had 
different haplotypes. This is consistent with what one 
would expect based on chance alone.
Individuals with PLMS are also shown in Figure 1. The 
frequency of PLMS in patients with the major form or the 
minor form of hyperekplexia and the healthy sibs is pre­
sented in Table PLMS occurs with high frequency in 
all three groups. Exclusion of tight linkage between the DNA 
markers and PLMS is evidenced by the highly negative lod 
scores obtained at small values of the recombination fre­
quency (Table 3). Interestingly, marker D5S209 yielded 
positive lod scores at higher recombination frequencies, con­
sistent with a location of PLMS more than 20 cM away from 
this marker. However, this tentative location was not con­
firmed by markers located at some distance of D5S209, such 
as D5S210 and D5S422.
By screening the exons of GLAR1 with DGGE, a 
change was found in exon 6 in a patient with the major 
form of hyperekplexia (patient IV-14). After cloning exon 
6 of this patient, sequencing eight clones showed that three 
had the wild type sequence, while five had a G to A mu­
tation in codon 271, reflecting the heterozygotic state of 
the patient. A patient (patient IV-11) with the minor form 
of hyperekplexia showed no change by screening with 
DGGE, and no further sequencing was performed. No 
changes were found with DGGE in a patient with PLMS 
(patient IV-19).
COMMENT
Clinical studies in families with hyperekplexia have re­
ported highly variable expression, including major and 
minor forms.1'8'11,13 This variability might in fact reflect
Table 2. The Frequency of Periodic Leg Movements 
During Sleep (PLMS) in Patients With the Major and 
Minor Forms of Hyperekplexia and in Healthy Sibs
PLMS
Diagnosis
Hyperekplexia 
Major form 
Minor form 
Healthy sibs
No. Present Absent ?
28
16
44
11
12
9
11
2
30
6
2
5
m
different origins for excessive startle responses. This could 
be investigated only when the cause could be ascer-
. As a first step in approac 
ogy, Ryan et aF recently reported linkage to the markers 
CSF1-R, D5S119, D5S209, and D5S379 in four families 
with an autosomal dominant 
additional studies based on the linkage results, point mu­
tations were found in GLAR1. In the families studied, stiff­
ness at birth and/or in relation to the startle reaction were 
invariably present and considered the criterion for the 
disease (major form).
In our family, comprising both the major and the 
putative minor form of hyperekplexia, we confirmed link-
CSF1 -R, mar
same 'sis was con
and the major form hyperekplexia locus. The same marker 
alleles that were shared by all patients with the major form 
were found only in a minority (three of 10) of the pa­
tients with the minor form, suggesting that the minor form 
is not part
firmed by screening GLRA1 with DGGE. Patients with 
the major form showed a mutation in exon 6. By se­
quencing exon 6, a G to A transition in codon 271 was 
found. Patients with the minor form did not have this 
mutation. Together, these results exclude the possibil­
ity that major and minor forms of hyperekplexia consti­
tute different phenotypes of the same, gene defect.
Therefore, the question arises whether the minor 
form does in fact constitute an integral part of the dis­
ease. A common genetic basis for the major and minor 
forms appeared to be plausible in the original evalua­
tion of this pedigree, as the major form was once trans­
mitted trough a patient with the minor form. However, 
it has subsequently become clear that this patient, who 
had not volunteered any information on stillness follow­
ing startle response, should be classified as having the 
major form of the disease based on independent family 
history information from several close relatives.
In other reports, the number of patients with stiff-
to reaction var-
ies. In most large families, all patients hi 
form.i,,5’u,14,1P’,2‘s However, in four families 
and the minor forms occurred. In these
jor was passed on as the minor m
ma-
'>,8-11)
It is important to realize that only one or two patients had 
the major form of hyperekplexia in these families.
occurrence
ekplexia are caused by a single gene defect, one might sug
Table 3. The lod Scores for Markers on Chromosome 5q for Periodic Leg Movements During Sleep (PLMS)
r
Theta
****** ^ s
Marker 0.0 0.01 0.05 0.1 0.2 0.3 0.4
D5S210 -15.037 -11.981 -7.478 —4.568 -1.599 -0.270 0.169
D5S207 -4.363 -3.477 -2.311 -1.458 —0.389 0.062 0.145
CSF1-R ” 4.516 -2.915 -1.159 -  0.273 0.305 0.217 ■“ 0,068
D5S209 -3.565 -1.518 0.610 1.545 2.022 1.708 0.950
D5S119 -4.511 -3.051 -0.979 0.204 1.154 1.194 0.696
D5S422 -9.552 -8,399 -5.808 -3.974 -1.877 ““0.744 —0.150
m M M N lH W l mjm
* Theta is the recombination fraction.
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gest alternatively that apart from the major hyperekplexia 
gene, on the chromosome 5q, another gene elsewhere in the 
genome is responsible for the minor form of hyperekplexia. 
The rarity of the disease makes the presence of two muta­
tions in one pedigree veiy unlikely. However, it remains pos­
sible that the occurrence of an excessive startle response 
as an autosomal dominant or sporadic trait may be much 
more common than previously believed.13 Obviously, startle 
responses are well known by all subjects in these pedigrees, 
increasing the chance that pronounced but normal startle 
reactions are considered abnormal in a hyperekplexia pedi­
gree. If so, linkage studies in hyperekplexia will be com­
plicated by the admixture of such “other” startle, responses. 
For a better discrimination between normal and abnormal 
startle reactions, the. normal variation in motor startle re­
actions should be delineated further through quantitative 
neurophysiologic investigations.
The occurrence of hypnagogic myoclonus and PLMS 
in the families with hyperekplexia presents another clas­
sification problem. Presumably, PLMS exists in 5% to 6% 
of the healthy population.24 We found an occurrence of 
PLMS of at least 21% in nonhyperekplectic sibs of pa­
tients with hyperekplexia. The distribution of PLMS over 
the pedigree suggests an autosomal dominant inheritance 
of PLMS, with incomplete penetrance, unrelated to hyper­
ekplexia. We hypothesized that a gene for PLMS might be 
located in the vicinity of the hyperekplexia locus and that 
recombination could account for the occurrence of PLMS 
without excessive startle reactions. This was not con­
firmed by a linkage study with three markers of the hyper­
ekplexia locus or with the markers tested further away on 
chromosome 5q.
In conclusion, the present molecular genetic re- 
evaluation of the Dutch family with hyperekplexia clearly 
demonstrates that only the major form constitutes part 
of the hyperekplexia phenotype. Stiffness, after the startle 
reaction and in the first years of life, is therefore the stron­
gest diagnostic criterion, even though the startle re­
sponses attract more attention.
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